Found 15928 matching trials
Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer
PHASE4The aim of this study was to evaluate the efficacy, safety and tolerability...
Location
Breast Cancer Center Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences
Safety and Efficacy of Infliximab in Palmoplantar Psoriasis
PHASE3Palmoplantar psoriasis is a variant of psoriasis affecting palms and soles....
Location
The Guenther Dermatology Research Center
Evaluate the Safety, Tolerability, PK and PD of SAD of Intravenously Adminsterted ALTB-268 in Healthy Participants
PHASE1This study with ALTB-268 will determine the safety, tolerability, pharmacok...
Status
Active Not Recruiting
Location
Syneos Health Clinical Research Services, LLC
Delayed Tolerance Through Mixed Chimerism
PHASE1This study will examine the safety and effectiveness of a bone marrow trans...
Status
Active Not Recruiting
Location
Massachusetts General Hospital
An Observational Study on Bevacizumab (Avastin) as First-Line Treatment in Colorectal Cancer Participants With Potentially Resectable Liver Metastases
N/AThis observational study will evaluate the efficacy and safety of bevacizum...
Location
Clinique Esquirol Saint Hilaire
Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs)
PHASE2The purpose of this study is to examine how effective rituximab or tocilizu...
Status
Active Not Recruiting
Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)
PHASE2This study is conducted in 3 stages. Stage 1 is an open-label, dose-escalat...
Location
Multiple Locations
Natalizumab Subcutaneous Immunogenicity and Safety Study
PHASE2The primary objective of this study is to evaluate the immunogenicity of na...
Sym004 in SCCHN Patients Failing Anti-EGFR Based Therapy
PHASE2The trial is designed as a multi-center, open label Phase 2 trial that inve...
Location
3203; Antwerp University Hospital; Department of Medical Oncology
Subcutaneously CM310/Placebo in Patients With Moderate-to-Severe Atopic Dermatitis (AD)
PHASE2This is a multi-center, randomized, double blind, placebo-controlled phase ...
Location
Beijing Chao-Yang Hospital, Capital Medical University